Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ: JAZZ )

122.24 -1.00 (-0.81%)
Streaming Delayed Price Updated: 12:44 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... 
Via Benzinga
Jazz Pharmaceuticals's Earnings: A Preview
Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2... 
Via Benzinga
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So.
Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regula... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is Jazz Pharmaceuticals Stock a Buy?
Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look. 
Via The Motley Fool
Where Jazz Pharmaceuticals Stands With Analysts
Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ... 
Via Benzinga
The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More
Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June
The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer
The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic... 
Via Benzinga
Exposures Product Safety
Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys
They are great options whether you are investing for the short or long term. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
Exposures Product Safety
Finding Value In Mid-Cap Stocks
Within the mid-cap space there is something for everyone. 
Via Talk Markets
New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or... 
Via Benzinga
14 Biotech Stocks To Watch Over The Next 6 Months
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Goldman Sachs lowered Casey's General Stores, Inc. (NASDAQ: 
Via Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
Via Benzinga
10 Biggest Price Target Changes For Monday
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading. SVB Leerink boosted Jazz... 
Via Benzinga
Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company... 
Via Benzinga
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
Cannabis investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce
2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the industr... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
6 Mid-Cap Gems for Growth at a Reasonable Price
A look at 6 attractively valued mid-cap stocks that are trading at valuations that are lower than their expected long-term growth rates. 
Via Talk Markets
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes. 
Via Investor's Business Daily
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Morgan Stanley boosted the price target on Applied Materials, Inc. (NASDAQ: AMAT) from $113 to $137. Applied Materials shares fell 1.1% to $123.46 in pre-market trading.... 
Via Benzinga
Cramer Advises Viewers On Suncor, Jazz And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that in the energy space he is recommending only Chevron Corporation (NYSE: CVX) and Pioneer Natural Resources... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More
This was an eventful week for the cannabis industry. On Monday, Tilray, Inc. (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.